CXCL9, CXCL10, and CXCL11 are upregulated in macrophages following immune checkpoint inhibitor treatment and associated with increased CD8+ T-cell infiltration into tumors [62], and they are found to be downregulated in COPD macrophages [54]. This evidence concerns the gene CXCL11 and chronic obstructive pulmonary disease.